WHITE PLAINS, NY – July 17, 2012 – Sunghee Cho, Ph.D., a principal scientific investigator at the Burke Medical Research Institute, has been selected to join the National Institutes of Health’s Neural Oxidative Metabolism and Death (NOMD) Study Section at the Center for Scientific Review. During her six-year term, beginning immediately, Dr. Cho will be collaborating with the 19-member team to make recommendations to the NIH national advisory council regarding NIH grant applications. She will be joining a distinguished group of scientists from great institutions such as Harvard Medical School, Yale University School of Medicine and The University of Chicago.
“Science is continuously moving and it always needs fresh ideas and different points of view,” Dr. Cho said. “It is an honor to be part of a team that helps move science forward by helping evaluate research proposals.”
Dr. Cho, director of Burke’s Preclinical Stroke Modeling laboratory and associate professor of Neurology and Neuroscience at Weill Cornell Medical College, was selected for her scientific research achievements and honors in the field of stroke and cerebral vascular disease. The committee reviews applications studying neurodegenerative diseases and neuronal cell death involving aging, among others. It also takes into account the basic aspects of disease, injury, repair and interventional strategies, as related to these studies.
According to Rajiv R. Ratan, M.D, Ph.D., executive director of the Burke Medical Research Institute and professor of Neurology and Neuroscience at Weill Cornell Medical College, "Dr. Cho's selection to serve on the NIH’s study section represents an enormous accomplishment in this highly competitive field.
“Her expertise in understanding the mechanisms of stroke and post-stroke recovery will be of great service to the NIH’s research efforts. We at Burke’s scientific community are quite proud of her appointment,” Ratan continued.
Richard Nakamura, Ph.D., acting director of the Center for Scientific Review, also added in a statement, [the study section’s] functions are of great value to medical and allied research in this country. Dr. Cho’s participation assures the quality of the recommendations to the NIH national advisory council and the NIH peer review process.
Funded by grants and private donations, Burke’s Medical Research Institute is involved in cutting-edge basic, translational and clinical research, providing new knowledge that can become the basis for future rehabilitation therapies in the areas of stroke, traumatic brain injury and spinal cord injury. The Institute has recently added new research laboratories in the areas of pain, vision restoration and motor recovery. The Institute strives to assist patients to recover more fully, not just to decrease disability, which has been the focus of mainstream rehabilitation research historically.
Burke Rehabilitation Hospital is a private, not-for-profit, acute rehabilitation hospital. Founded in 1915, it is the only hospital in Westchester County dedicated solely to rehabilitation medicine. Burke offers both inpatient and outpatient programs for those who have experienced a disabling illness, traumatic injury or joint replacement surgery. Burke is both an acute rehabilitation hospital and medical research center. Burke’s world-renowned doctors and therapists provide state-of-the-art-treatment, while its research scientists at the Burke Medical Research Institute explore the frontiers of neurological and rehabilitation medicine. All share the Burke mission to ensure that every patient makes the fullest possible recovery from illness or injury regardless of their ability to pay.